TSM Associates

Most Requested News

15% of Cervical Cancer Patients Treated with Advaxis' ADXS11-001 Still Alive Three Years after Initial Dosing

"47% drop in EBITDA at WPP"

"Scrutiny of publication bias increases"

"Hospital billing offices are starting to act like used car lots"

"Integrating EU and US regulation"

"Polio surge in Nigeria after vaccine virus mutates"

"Probing Doctors' Ties to Industry"

"Make primary care worth docs' while"

"NYT: Docs at top medical schools have been engaging ghostwriters"

"Products achieving the greatest sales in first full year on the US market in 2008"

"Our Health Care Crisis: Age, Obesity, Lawyers"

"NEJM: Put comparative effectiveness on labels"

"Safety concerns again halt world's first human trial of an embryonic stem cell therapy"

Congress Says Appendectomy is Interstate Commerce but Insurance Sales is Not

NEJM: Antigenicity of the tumor cell - context matters

Inside China's vaccine laboratories

"Takeda reacquires Canadian commercial rights to ACTOS from Lilly"

Battle over biosimilar drugs starts to heat up in FL

Heat Bio gets $5M for Ph 2 of HSP inh in NSCLC, bladder Ca

While Walgreen & Express Scripts feud, CVS takes lunch money

"We didn't cause the crisis": Purdue's David Sackler pleads case

White House officials have soured on HHS Secretary Alex Azar

Using CRISPR to resurrect the woolly mammoth - Cnet

Senate committee holds hearing on its big health care package

Quality standards for biologics protect patients, it's not optional

Medivir encouraged by Ph 2b interim analysis for TMC435 w/ peg-IFN and ribavirin in gen-1 hep-C

EvaluatePharma: World Preview 2019, Outlook to 2024 report

Fewer players but it's still a war in the distribution channel - Motley Fool

After decades of improvement, US air quality slipped last 2 yrs

Meharry, historically black med school in TN rejects Juul's $7.5M

FDA revamps ANDA paragraph IV certifications list

Zolgensma in SMA: An ICER analysis and a poorly justified price

New thinking and knowledge of CRISPR and off-target analysis

Here's a twist, J&J hints that markets outside the U.S. might suffer a greater proportion of layoffs

Confidential deal makes Amgen's Blincyto available to NHS

"The Agenda Behind Mylan's Suit v. the Pittsburgh Post-Gazette"

Biologists win Nobel for work on cells' molecular transport

New blood test detects H5N1 flu infection in 2 hours

FDA adv panel recs approval of BMS' dapaglifozin in T2D

No evidence biologics require longer devt time vs small-molecules

Scan MRI differences in MS differentiate cognitive impairment

Squandered 'Big Tobacco" $$, a cautionary tale in opioid cases

Actelion shakes up board, appoints COO

An MS patient laments learning of her docs' pharma COI

CRM today is good at managing transactions and providing management reports but for the most part, it's a useless burden for salespeople

Covance's early devt VP talks about CMC, Sanofi, and more

Generic drugs get a bad rap. Why? They are the same

Compounding pharmacies are feeling more regulatory heat

An FDA approval could come at a major cost for patients

AstraZeneca working toward Alzheimer's disease treatment

SelectHealth paid $1M last year to provide 5 pats with Cerezyme in Gaucher's

AEI: Testimony on the Lower Health Care Costs Act

Medicines Co: Cangrelor beats Plavix in Ph 3 as bridge to CABG

Eleven US cancer centers get to charge more for care

FDA adv cmte unanimously recs GSK's Q-Pan H5N1 vax

Top 10 blockbuster drugs in the late-stage pipeline - Evaluate

Cell: The importance of increasing diversity in genetic research

More than a third of us may have obstructive sleep apnea

Uganda clears 3 experimental Ebola Txs, watches for spread

France leads the world in mistrust of vaccines

Common nerve pain drug, Lyrica linked to suicidal behavior, OD

Gilead and Nurix in $2.5B deal to focus on protein degradation

Sleep trackers provide inaccurate data, increase sleep anxiety

"Genes for Good": Genetics research gets help from social media

Biohaven takes a billion-dollar bath before share offering

Eisai receives approval for Halaven in South Korea & Australia

French drugmaker Sanofi, Google to use data tech for RWE

CMS proposes update to e-Rx standards: Online prior auth

Physical un-fitness linked with depression, anxiety in mid-life

China trial: Adding Plavix to ASA cuts repeat strokes by 32%

Strobing stage lights could up risk of epileptic seizures

AZ's Lynparza gets EU nod as firin 1st-line ovarian Ca maint

Wellcome Trust: Varying vax trust leaves populations vulnerable

India's pharma biz could benefit from Sino-American trade rift

Roche wins Japan approval for personalized Ca drug, Rozlytrek

Request a Call!

Please click here to Request a Call for everything from 24-hr professional turnaround of secondary research summaries and white papers to experienced consulting services for temporary staffing solutions or project management (or reach us directly at 610-952-1871)

TSM Associates are…

Creative
Experienced
Committed

We Are FULL-SERVICE BioPharmaceutical Marketing Consultants

Market Research
Project Management
Sales Forecasting
Sales Analytics
Brand Management
Payer Marketing and Analytics
Strategy Development
Commercial Opportunity Assessment
Agency Management: Positioning, Messaging, Creative

Licensing - Business Development
Media Planning
Promotional Regulatory Affairs
Launch Planning
Trade Relations and Strategy
Advocacy Development
Tactical Planning
Sales and Sales Management
Sales Training
Management Training